Serena Nik-Zainal, Department of Medical Genetics and MRC Cancer Unit, University of Cambridge. Picture: Courtesy of Serena Nik-Zainal.
The Dr. Josef Steiner Cancer Research Award for 2019, endowed with €900,000 and originally referred to as the "Nobel Prize for Cancer Research", is going to Prof. Serena Nik-Zainal of the University of Cambridge. Thanks to her research, mutations in cancerous tumors can be analyzed using new bioinformatic methods, which makes new targeted therapy approaches possible. The prize is being awarded today at the University of Bern. Today, the Dr. Josef Steiner Cancer Foundation, which is comprised of physiologists from the Universities of Bern, Geneva and Zürich and chaired by the member from Bern, is awarding the Dr. Josef Steiner Cancer Research Award 2019 to Prof. Serena Nik-Zainal. The bioinformatician from the Department of Medical Genetics and the MRC cancer unit at the University of Cambridge is receiving the award in recognition of her groundbreaking research in developing new methods in the field of bioinformatics for the clinically-relevant classification of tumors. It is the first time that the Dr. Josef Steiner Cancer Research Award goes in full to a women scientist. The award, which was donated in the 1980s by Dr. Josef Steiner, a pharmacist from Biel/Bienne, is being staged for the 21st time this year.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
